Summary

In this Associate Director level role, you will help advance epidemiology and real-world evidence strategies for assigned assets, disease areas, and research programs. You will play a key role in generating and applying epidemiologic evidence that informs development, regulatory, access, commercialization, and lifecycle decisions. Your work will contribute to identifying evidence gaps, strengthening integrated evidence plans, and supporting informed decision-making across the product lifecycle. You will be part of a collaborative, cross-functional environment, working closely with colleagues across research, development, and commercial teams to address important evidence needs. By applying rigorous observational research methods, real-world data, advanced analytics, digital tools, and AI-enabled approaches, you will help deliver evidence that supports regulatory success, patient access, scientific credibility, and asset differentiation.

Job description

About the Role

In this Associate Director level role, you will help advance epidemiology and real-world evidence strategies for assigned assets, disease areas, and research programs. You will play a key role in generating and applying epidemiologic evidence that informs development, regulatory, access, commercialization, and lifecycle decisions. Your work will contribute to identifying evidence gaps, strengthening integrated evidence plans, and supporting informed decision-making across the product lifecycle. You will be part of a collaborative, cross-functional environment, working closely with colleagues across research, development, and commercial teams to address important evidence needs. By applying rigorous observational research methods, real-world data, advanced analytics, digital tools, and AI-enabled approaches, you will help deliver evidence that supports regulatory success, patient access, scientific credibility, and asset differentiation.

How You Will Contribute

Partner with cross-functional teams to inform program strategies and integrated evidence plans while ensuring epidemiologic evidence is relevant and effectively communicated.
Provide epidemiology expertise to support asset strategies, clinical development plans, regulatory activities, lifecycle planning, launch readiness, and commercialization efforts.
Generate and interpret evidence to support key decisions related to indication prioritization, population estimates, patient segmentation, trial feasibility, endpoint selection, and development planning.
Identify and evaluate data sources including claims data, electronic health records, registries, natural history datasets, biobanks, and other real-world data assets.
Design and execute observational studies using appropriate methods and analytical approaches to address prioritized evidence questions.
Author and review scientific materials including protocols, analysis plans, study reports, publications, regulatory submissions, and other evidence communications.
Manage research partners and vendors to deliver high-quality studies on time, within budget, and in compliance with applicable standards.
Apply innovative technologies and methods including digital tools, advanced analytics, data visualization, and AI-enabled approaches to strengthen evidence generation.

Qualifications

Advanced degree in epidemiology, pharmacoepidemiology, public health, biostatistics, health services research, outcomes research, decision sciences, or a related field.
Practical experience conducting epidemiology, outcomes research, or real-world evidence studies within a life sciences company, research organization, academic institution, or government agency.
Experience in drug development and understanding of the role of observational research across development and commercialization activities.
Demonstrated ability to design, conduct, and interpret complex observational studies.
Understanding of regulatory and payer evidence requirements.
Strong collaboration, communication, influencing, and project management skills in matrixed environments.
Experience managing research partners, vendors, multiple priorities, and complex projects.
Strong scientific communication skills with the ability to clearly present complex findings to diverse audiences.

Requirements

Advanced degree in epidemiology, pharmacoepidemiology, public health, biostatistics, health services research, outcomes research, decision sciences, or a related field.
Practical experience conducting epidemiology, outcomes research, or real-world evidence studies within a life sciences company, research organization, academic institution, or government agency.
Experience in drug development and understanding of the role of observational research across development and commercialization activities.
Demonstrated ability to design, conduct, and interpret complex observational studies.
Understanding of regulatory and payer evidence requirements.
Strong collaboration, communication, influencing, and project management skills in matrixed environments.
Experience managing research partners, vendors, multiple priorities, and complex projects.
Strong scientific communication skills with the ability to clearly present complex findings to diverse audiences.

Company overview

Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company founded in 1781 and incorporated in 1925. As one of the world's top 20 largest pharmaceutical companies by revenue and the third largest in Asia, Takeda specializes in developing and commercializing innovative medicines across several therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. With approximately 49,095 employees globally, the company operates research and development centers, manufacturing facilities, and commercial operations across 39 U.S. states and numerous countries worldwide. Takeda maintains dual headquarters in Tokyo and Osaka, Japan, with significant operations in Cambridge, Massachusetts, where it serves as the largest life sciences employer in the state. The company's patient-focused approach is guided by its Takeda-ism values of Integrity, Fairness, Honesty, and Perseverance, emphasizing a commitment to delivering life-transforming treatments while advancing sustainable healthcare solutions. Takeda's extensive portfolio includes both innovative biologics and small molecule drugs, supported by strategic acquisitions and partnerships that have expanded its capabilities in areas such as immuno-oncology and rare disease treatments.